Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), IRCCS San Raffaele Hospital, Milan.
Vita-Salute San Raffaele University, Milan.
Rheumatology (Oxford). 2020 Sep 1;59(9):2523-2533. doi: 10.1093/rheumatology/kez658.
To outline the clinical, histological and prognostic features of systemic sclerosis (SSc) endomyocardial biopsy-proven myocarditis with respect to those of diverse endomyocardial biopsy-proven virus-negative myocarditis (VNM).
We retrospectively analysed data from three cohorts of endomyocardial biopsy-proven myocarditis: SSc-related VNM (SSc-VNM); isolated VNM (i-VNM); and VNM related to other systemic autoimmune diseases (a-VNM). The degree of myocardial fibrosis was expressed as relative percentage and fibrotic score (0-3). Clinical data, cardiac enzymes, echocardiogram, 24 h ECG Holter and cardiac magnetic resonance were obtained at baseline and during follow-up. Non-parametric tests were used.
We enrolled 12 SSc-VNM [11 females, mean age 49.3 (14.2) years; seven diffuse-SSc, five early-SSc], 12 i-VNM [12 females, mean age 47.7 (10.8) years] and 10 a-VNM [four females, mean age 48.4 (16.3) years] patients. SSc patients had higher degrees of myocardial fibrosis as assessed by both percentage [SSc-VNM: 44.8 (18.8)%; a-VNM: 28.6 (16.5)%; i-VNM: 24.9 (10.3)%; P = 0.019] and score [SSc-VNM: 2.3 (0.8); a-VNM: 1.4 (1.1); i-VNM: 1.2 (0.7); P = 0.002]. Myocardial fibrosis directly correlated with skin score (r = 0.625, P = 0.03) and number of ventricular ectopic beats on 24 h ECG Holter in SSc patients (r = 0.756, P = 0.01). Dyspnoea class was higher at presentation in SSc-VNM patients (P = 0.041) and we found heart failure only in SSc patients (25%) (P = 0.05). At cardiac magnetic resonance, myocardial oedema was nearly undetectable in SSc-VNM patients compared with others (P = 0.02). All patients received immunosuppressive treatment. The number of patients who died during follow-up due to cardiac complications was significantly higher in SSc-VNM patients (50%), as compared with a-VNM (0%) and i-VNM (8.3%) patients (P = 0.006). Patients who died during follow-up had higher degrees of myocardial fibrosis [52.2 (11.6)% vs 27.5 (12.9)%, P = 0.024; fibrotic score: 2.83 (0.41) vs 1.4 (0.9), P < 0.001].
SSc has unique clinical and histological features, as it tends to present more frequently with heart failure and a higher dyspnoea class and to show higher degrees of myocardial fibrosis. These specific features are paralleled by a worse cardiac prognosis.
概述系统性硬化症(SSc)心肌活检证实心肌炎的临床、组织学和预后特征,以及不同心肌活检证实病毒阴性心肌炎(VNM)的特征。
我们回顾性分析了三个心肌活检证实心肌炎队列的数据:SSc 相关 VNM(SSc-VNM);孤立性 VNM(i-VNM);以及与其他系统性自身免疫性疾病相关的 VNM(a-VNM)。心肌纤维化程度用相对百分比和纤维化评分(0-3)表示。基线和随访时获取临床数据、心脏酶、超声心动图、24 小时心电图 Holter 和心脏磁共振。采用非参数检验。
我们纳入了 12 例 SSc-VNM [11 例女性,平均年龄 49.3(14.2)岁;7 例弥漫性 SSc,5 例早期 SSc]、12 例 i-VNM [12 例女性,平均年龄 47.7(10.8)岁]和 10 例 a-VNM [4 例女性,平均年龄 48.4(16.3)岁]患者。通过百分比和评分评估,SSc 患者的心肌纤维化程度更高[SSc-VNM:44.8(18.8)%;a-VNM:28.6(16.5)%;i-VNM:24.9(10.3)%;P=0.019]和评分[SSc-VNM:2.3(0.8);a-VNM:1.4(1.1);i-VNM:1.2(0.7);P=0.002]。在 SSc 患者中,心肌纤维化与皮肤评分(r=0.625,P=0.03)和 24 小时心电图 Holter 室性异位搏动数(r=0.756,P=0.01)直接相关。在 SSc-VNM 患者中,呼吸困难的发生率更高(P=0.041),并且我们仅在 SSc 患者中发现心力衰竭(25%)(P=0.05)。与其他患者相比,在心脏磁共振上,SSc-VNM 患者的心肌水肿几乎不可检测(P=0.02)。所有患者均接受免疫抑制治疗。在随访期间,由于心脏并发症而死亡的患者中,SSc-VNM 患者(50%)明显高于 a-VNM 患者(0%)和 i-VNM 患者(8.3%)(P=0.006)。在随访期间死亡的患者的心肌纤维化程度更高[52.2(11.6)%比 27.5(12.9)%,P=0.024;纤维化评分:2.83(0.41)比 1.4(0.9),P<0.001]。
SSc 具有独特的临床和组织学特征,其心力衰竭发生率更高,呼吸困难程度更高,且心肌纤维化程度更高。这些特定特征与更差的心脏预后相关。